Loading…
Lobbying Spend
—
Filings
76
Firms Hired
1
Active Period
2001–2024
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: H.R.830
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: S.652
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: H.R.830
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: S.652
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: H.R.830
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: S.652
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: H.R.830
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: S.652
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: H.R.830
Research in rare Kidney Disease FDA drug development Rare Kidney Disease legislation CDC Chronic Disease Education and Awareness S.652 - Safe Step Act H.R.830 - HELP Copays Act
Client expense: — · Firm income: $10,000
Matched citations: S.652
Access to Marketplace Insurance Act
2016 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 3742: Access to Marketplace Insurance Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3742
Access to Marketplace Insurance Act
2016 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 3742: Access to Marketplace Insurance Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3742
Access to Marketplace Insurance Act
2015 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 3742: Access to Marketplace Insurance Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 3742
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1325
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Client expense: — · Firm income: $10,000
Matched citations: S. 323
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1325
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Client expense: — · Firm income: $10,000
Matched citations: S. 323
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1325
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Client expense: — · Firm income: $10,000
Matched citations: S. 323
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Client expense: — · Firm income: $10,000
Matched citations: H.R. 1325
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2013
2014 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 1325 / S. 323: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act
Client expense: — · Firm income: $10,000
Matched citations: S. 323
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
2013 · fourth_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2969
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
2013 · third_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2969
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
2013 · second_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2969
Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
2013 · first_quarter · Firm: HEALTH AND MEDICINE COUNSEL, LLC
Research in Kidney Disease FDA drug development H.R. 2969: Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act of 2011
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2969
Source: Senate LDA